Jorind Beqari

Harvard University

Papers

1

Total Citations

25

H-Index

1

About

Jorind Beqari is a surgical researcher whose work focuses on optimizing oncologic outcomes in thoracic surgery, particularly for thymic malignancies. His most-cited study, a 2022 national analysis of open versus minimally invasive thymectomy for stage I–III thymic carcinoma, has garnered 25 citations and provides critical evidence on the oncological efficacy of video-assisted thoracoscopic and robotic approaches. Using the National Cancer Database, Beqari demonstrated that minimally invasive techniques can achieve comparable survival outcomes to open surgery while potentially reducing perioperative morbidity—a finding that directly informs surgical decision-making for this rare cancer. This work underscores his broader contributions to comparative effectiveness research in thoracic oncology, where he systematically evaluates how surgical innovations impact both short-term recovery and long-term survival. By challenging traditional paradigms with population-level data, Beqari helps bridge the gap between technological advancement and evidence-based practice. His research is particularly valuable for surgeons and trainees navigating the shift toward less invasive approaches, offering reassurance that oncologic principles need not be compromised for improved recovery.

Research Focus

Key Achievements

1
H-Index
1
Papers
25
Total Citations
25
Avg Citations/Paper
🏆 Most Cited Paper
A national analysis of open versus minimally invasive thymectomy for stage I–III thymic carcinoma
25 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Harvard University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago